We have previously shown that noninfected human T-cell lines express the canonical 5.7 kb mRNA coding for the type b platelet-derived growth factor-receptor (PDGF breceptor), whereas HTLV-I-infected T-cell lines express a novel PDGF b-receptor mRNA of 3.8 kb. In this report, we have extended those studies to molecularly characterize the 3.8 kb PDGF b-receptor mRNA and show that it has resulted from integration of an apparently undeleted HTLV-I provirus into the PDGF b-receptor gene in an orientation enabling expression of a truncated PDGF b-receptor mRNA using the 3' HTLV-I long terminal repeat as a promoter. Further, NIH3T3 cells transfected with a plasmid containing the truncated PDGF b-receptor ORF plasmid generate colonies in soft agar with more cells per colony than untransfected cells, or cells transfected with the Tax 1 or PDGF-B (c-sis) plasmids. These results indicate that the truncated PDGF b-receptor protein acquires transforming capability and that HTLV-I-induced truncation of PDGF b-receptor may correlate with HTLV-I-associated neoplasia of human T-cells.
Introduction
The human T-cell leukemia-lymphoma virus, HTLV-I, is critical in the development and progression of eudemically clustered adult T-cell leukemia-lymphoma (ATL) patients (Poiesz et al., 1980; Hinuma et al., 1981; Watanabe et al., 1984) . In ATL, the tumor cells harbor one or more copies of HTLV-I although the provirus often shows extensive deletion in the gag and/or pol genes (Seiki et al., 1982; Korber et al., 1991; Ohshima et al., 1991) . In vitro, infection of human T-cells with HTLV-I leads these cells to immortalization (Salahuddin et al., 1984; Markham et al., 1983; Popovic et al., 1983) . Unlike most other highly oncogenic retroviruses, the HTLV-I genome does not encode transforming sequences, i.e. viral oncogene(s), with nucleic acid homology to normal cellular sequences, proto-oncogene(s) (Shimotohno et al., 1984) . Moreover, the sites of proviral integration vary from tumor to tumor Seigel et al., 1986) , and this has suggested that the transforming ability of HTLV-I is mediated by the viral transactivator protein Tax which can activate cellular genes involved in cell proliferation (Sodroski et al., 1984 (Sodroski et al., , 1985 Felber et al., 1985) . One mechanism postulated to account for the transforming potential of HTLV-I on T-cells is an autocrine loop involving interleukin-2 (IL-2) and IL-2-receptor (IL-2R) expressed in cells cultured from ATL patients (Depper et al., 1984; Umadome et al., 1988; Marriott et al., 1992) . However, freshly isolated ATL cells do not synthesize Tax RNA or protein, precluding Tax transactivation as the mechanism through which the virus might act to drive proliferation in the end-stage tumor cell (Ratner et al., 1985; Sakurai et al., 1992) . Further, some HTLV-I infected T-cell lines do not synthesize IL-2 and thus an IL-2-IL-2R autostimulatory loop cannot be a general mechanism of transformation of human T-cells by HTLV-I (Arya et al., 1984) .
In search of other mechanisms of autostimulation of proliferation of HTLV-I-infected cells, we have reported that some noninfected T-cell lines synthesize platelet-derived growth factor-receptor, type-b (PDGF b-receptor, product of the PDGFRB locus), but not its ligand PDGF-B, whereas several HTLV-I-infected Tcell lines synthesize both PDGF-B and proteins related to the PDGF b-receptor (Goustin et al., 1990; Pantazis et al., 1987 Pantazis et al., , 1990 . Because of these ®ndings, we initially hypothesized a loop involving PDGF breceptor and PDGF-B as another autostimulatory mechanism of proliferation of HTLV-I-infected Tcells (Goustin et al., 1990; Pantazis et al., 1987 Pantazis et al., , 1990 . Further, it was those studies in which we ®rst observed that HTLV-I-infected T-cells express a truncated PDGF b-receptor mRNA of 3.8 kb, whereas the canonical transcript is about 5.7 kb long (Goustin et al., 1990; Pantazis et al., 1987 Pantazis et al., , 1990 .
Like many growth factor-receptors, the canonical PDGF b-receptor has an amino-terminal extracellular ligand-binding domain (LBD), an intracellular tyrosine-kinase domain (TKD) responsible for transducing the mitogenic signal, and a transmembrane domain (TMD), between LBD and TKD, that is, the cell membrane-anchoring segment of the receptor molecule (reviewed by Claesson-Welsh, 1994) .
In general, the tyrosine kinase activity of the PDGF b-receptor is dependent upon binding of the ligand (Claesson-Welsh, 1994) . However, it has been reported that in chronic myelomonocytic leukemia (CMML) cells bearing a t(5;12) chromosomal translocation, the tel gene drives expression of a fusion transcript of tel and PDGF b-receptor (Golub et al., 1994) . In one of the cases analysed, the N-terminus of tel (bearing a helix ± loop ± helix domain) is fused to the C-terminal half of the PDGF b-receptor, just upstream of the PDGF b-receptor transmembrane domain at residue 526 (Golub et al., 1994) . In this tel-PDGF b-receptor fusion protein, the ligand-binding domain of the PDGF receptor is absent, but the TM domain and both TK domains are intact (Golub et al., 1994) .
In this report, we demonstrate that HTLV-I-infected human T-cells, C10/MJ, express an mRNA transcript that has resulted from integration of an undeleted HTLV-I provirus into one of the PDGF b-receptor alleles. In turn, the 3'-HTLV-I LTR drives expression of the PDGF b-receptor gene to form a truncated PDGF b-receptor product lacking the ligand-binding domain, but capable of transforming NIH3T3 cells.
Results
Northern blot analysis using various PDGF b-receptor cDNA probes Figure 1b shows the results of dierential probing of Northern blots of poly(A) + RNA from HTLV-Iinfected C10/MJ and uninfected HSB-2 cells, a human T-lymphoblastoid line. The three cDNA probes used in these studies represent selected regions of the canonical PDGF b-receptor mRNA (depicted in Figure 1a) , and are described in more detail below (see Hybridization probes, in Materials and methods). The N-terminal bR507 probe recognizes a 5.7 kb transcript in HSB-2 cells, but no transcript is recognized in C10/MJ cells. Similar results are obtained with the ectodomain probe bR960. However, the bR33 probe recognizes a 5.7 kb transcript in HSB-2 cells and a 3.8 kb transcript in C10/MJ cells. The 3.8 kb transcript produces a much stronger signal than the 5.7 kb transcript, despite the fact that the HSB-2 lane was loaded with 3.5 times more RNA than the C10/MJ lane. These results demonstrate that the 3.8 kb PDGF b-receptor-related mRNA from C10/MJ cells lacks sequences encoding the ectodomain and the transmembrane domain present in the canonical 185 kb human PDGF b-receptor.
Sequence analysis of cDNA clones
Four independent cDNA clones were identi®ed using the C-terminal PDGF b-receptor probe bR33 to screen a lgt11 cDNA library constructed from C10/MJ cells. One clone, bR08, with an insert of 2.05 kb was particularly interesting, featuring 109 bp of sequence at its 5'-end unrelated to PDGF b-receptor (Figure 2 Of these stop codons, three are in frame with the proposed MET initiator codon, underlined in Figure 2 . Such an ORF would predict a truncated PDGF breceptor-related tyrosine kinase of 58 297 daltons, featuring both tyrosine kinase domains TK1 and TK2 and the kinase insert (KI) domain, a site known for interaction of the PDGF receptor with the critical signal transduction eectors rasGAP and the 85 kD regulatory subunit of phosphatidylinositol-3-kinase (Fantl et al., 1992) . A potential myristoylation site at codon 37 (GLY) in the unique 522 codon ORF is also predicted, but this site is embedded in the TK1 domain ( Figure 2 ).
Analysis of genomic clones ampli®ed from C10/MJ cells
Analysis of genomic clones from C10/MJ cells was undertaken to identify the precise site of integration of the HTLV-I provirus into one of the PDGF b-receptor alleles. PCR ampli®cation using the PDGF b-receptor transmembrane exon sense amplimer K3: 5'-CATCTCCCTTATCATCCTCATCA-3' and the Junctional fragments shown were generated by PCR using the indicated primer pairs (K3/ASG11 and HTLK2/KDC2). The PCR products were sequenced from plasmid clones and a restriction map generated. The size and site of proviral insertion in these cloned junctional fragments is consistent with the insertion of a provirus in a PDGF b-receptor intron of 944 bp; the sequence of the uninterrupted intron is given in Figure 4 results demonstrate a weak transforming ability of the HTLV-I-derived transactivator protein, Tax, an observation made by others (Tanaka et al., 1990) . Nevertheless, there was a clear dierence between the bR08 transfectants and the Tax transfectants in their ability to grow in soft agar, contrasting a rather weak transforming ability of Tax with the more potent transforming ability of the truncated PDGF breceptor-related tyrosine kinase. These results suggest that the 522 aa PDGF b-receptor ORF encodes an oncoprotein capable of transforming NIH3T3 cells.
Discussion
In this report we have demonstrated that HTLV-Iinfected human T-cells (C10/MJ) synthesize a novel mRNA transcript consisting of proviral sequences of HTLV-I and cellular sequences encoding a portion of PDGF b-receptor. Since the initial report of the association of HTLV-I provirus and ATL (Reitz et al., 1981 ) the role of the provirus remains unclear. It has been demonstrated that at least six dierent cellular genes (IL-2, IL-2R, PDGF-B, vimentin, c-fos and GM-CSF) are activated by the provirus-encoded Tax1 protein, which acts as a transactivator of cellular gene promoters (Sodroski, 1992; Trejo et al., 1996) . Curiously, the pX region of the provirus, encoding the Tax transactivator is invariably retained (Korber et al., 1991) , despite the fact that the end-stage tumor cells rarely express Tax RNA or protein, possibly due to methylation of the proviral LTR (Saggioro et al., 1990) . Although the pX region and the downstream LTR are invariably conserved even in deleted proviruses, few studies have considered the possibility that this LTR might function to drive downstream cellular genes, probably because of early and in¯uential ®ndings failing to ®nd a common HTLV-I integration site in ATL tumor cells Seigel et al., 1986) . Our results show that integration of the HTLV-I provirus into the PDGF b-receptor gene results in à proviral-cellular' hybrid gene whose expression is regulated by the 3'-LTR. In turn, this indicates that the proper orientation of the LTR in the hybrid gene gives the viral enhancer direct access to the PDGF breceptor promoter. In a related recent report, it has been shown that a naturally occurring product of fused tel and PDGF b-receptor genes is present in chronic myelomonocytic leukemias (CMML) with t(5;12) chromosomal translocation (Golub et al., 1994) . In cells bearing such translocation, the fused tel moiety contains a distinct domain, known as 5-'HLH, that is essential for full transactivating function of tel as well as other members of the Ets gene family Siddique et al., 1993) . In CMML cells, the tel-PDGF breceptor fusion protein is unique in that only the 5'- Figure 4 Nucleotide sequence of the normal PDGF b-receptor gene between the transmembrane (TM) and juxtamembrane exons. Shown is the nucleotide sequence of the cloned PCR product derived from normal human DNA (JEG-3 cells) ampli®ed using the PDGF b-receptor amplimers K3 and KDC2. The same strategy was used to amplify a similar product from the uninterrupted PDGF b-receptor allele in C10/MJ cells; noted below positions 623 and 816 are nucleotide substitutions found in the uninterrupted normal PDGF b-receptor allele in the T lymphocyte line C10/MJ. Also indicated are the locations of the PCR ampli®cation primers K3 and KDC2 as well as sequencing primers IP1, IP4 and IP7 used in dye terminator sequencing reactions. This sequence has been submitted to GenBank and assigned accession number U33172 Figure 5 Transfection of a truncated PDGF b-receptor expression construct is able to transform NIH3T3 cells. Subcon¯uent monolayers of NIH3T3 (6 cm plates) were transfected 2 mg of plasmid DNA encoding the truncated PDGF b-receptor (pRSVbR08), the normal human PDGF-B chain (pSM-1), the 353 aa HTLV-I Tax1 open reading frame (pRSV-Tax1) or mocktransfected. Foci were cloned with cloning cylinders after 10 ± 14 days growth in 0.3% calf serum and 3000 cells were used to seed growth in 0.3% agarose; cells per colony were counted after 7 days HLH domain of tel is incorporated into the fusion product, excluding the tel DNA-binding moiety functioning in malignancies involving other Ets family members (Moreau-Gachelin et al., 1989; Delattre et al., 1992; Shimizu et al., 1993; Sorensen et al., 1994) . Thus, chromosomal alterations involving the PDGFRB locus may be critical to the development of myelomonocytic leukemias. But what about HTLV-I-associated leukemias? Recently, Kubota et al. (1996) have shown that integration of the HTLV-I provirus upstream of the ®rst coding exon of the IL-9 receptor in MT-2 cells results in a fusion transcript encoding a normal IL-9 receptor and Bamford et al. (1996) have demonstrated HTLVintegration upstream of the IL-15 coding region. Thus, it appears that integration of proviral DNA into a cytokine or growth factor receptor gene may be one of the ways HTLV-I induces cellular transformation.
Some leukemia viruses such as avian leukosis virus (ALV) initiate the transformation process in vitro by integrating the proviral DNA in the vicinity of a cellular oncogene, which subsequently is inappropriately expressed, and occasionally altered to encode a protein dierent from the wild-type (Hayward et al., 1981) . In the HTLV-I-infected line C10/MJ, integration of the proviral DNA into the PDGF b-receptor gene results in a new PDGF b-receptor protein product missing the ligand-binding domain but retaining the tyrosine-kinase domains. Similar Nterminal truncation of growth factor receptor tyrosine kinases is a common ®nding in diverse cell types, including truncation of erbB, HER2/neu, kit, ros, met, ret and trk oncogenes. In many cases, truncation of growth factor receptors results in a constitutive tyrosine-kinase activity. The truncated PDGF breceptor gene described here involves deletion of the ligand-binding domain of the normal PDGF breceptor. The transforming ability of the truncated PDGF b-receptor hybrid protein has been demonstrated by the ability of NIH3T3 transfection constructs to induce colonies in soft agar. Specifically, these cells were 2.456 more ecient than NIH3T3 cells transfected with either Tax or PDGF-B constructs in the ability to form colonies in soft agar ( Figure 5 ). Moreover, 3T3 cells transformed with the truncated b-receptor construct (pRSV-bR08) were able to establish tumors when injected into nude mice, unlike any of the other transfectants (data not shown).
The ®ndings reported here demonstrate that integration of proviral DNA into the PDGF b-receptor of the HTLV-I-infected C10/MJ cells can result in a truncated PDGF b-receptor protein which exhibits transforming ability. Combined with the recent reports of Kubota et al. (1996) on HTLV-I LTR-driven expression of the IL-9 receptor in the MT-2 line and Bamford et al. (1996) on the IL-15 gene in HuT-102 cells, our results suggest that a subset of HTLV-I-mediated transforming events may occur via a promoter insertion mechanism in which a retroviral LTR drives expression of a cellular gene. This hypothesis is supported by the fact that most ATL cells contain a HTLV-I provirus integrated in a monoclonal pattern (Kettman et al., 1982; Van den Broeke et al., 1988) , even though proviruses in dierent individual tumors are found to be integrated in diverse regions of the host genome Seigel et al., 1986) . Such insertional activation events might target a small but diverse group of cellular genes critical to cellular regulation in the mature T-lymphocyte, the general target for HTLV-I integration, and proposed precursor to HTLV-I-related malignancy (cutaneous T-cell lymphoma and adult T-cell leukemia-lymphoma).
Materials and methods

Cell lines
The uninfected human T-lymphoblastoid cell line CCRF-HSB-2 (ATCC CCL-120.1), JEG-3, and NIH3T3 mouse ®broblasts (ATCC CRL-1658) were obtained from the American Type Culture Collection (Rockville, MD). The HTLV-I-infected T-lymphocyte line C10/MJ was obtained from Dr VS Kalyanaraman (Goustin et al., 1990) . This line derives from co-cultivation of PHA-activated umbilical cord blood lymphocytes (donor C10) with X-irradiated cells, derived from a 50-year-old white male (MJ) diagnosed with cutaneous T-cell lymphoma . The C10/MJ cell line was ®rst described by Salahuddin et al. (1983) . Both T-cell lines were cultured in 10% fetal calf serum (Gibco Life Technologies, Gaithersburg, MD) plus RPMI 1640 supplemented with 25 mM HEPES, pH 7.4. NIH3T3 cells were standardly grown in DMEM supplemented with 10% calf serum, split 1 : 3 twice per week; cells were discarded after six passages.
Hybridization probes
The three PDGF b-receptor cDNA probes used in this study were constructed to represent speci®c segments of the canonical 5.7 kb human PDGF b-receptor mRNA (Gronwald et al., 1988) . The bR507 probe includes 26 nt of the 5'-UT of the canonical PDGF b-receptor cDNA plus 481 bp encoding the signal sequence and part of the ectodomain (nt 314 ± 821 in GenBank ®le J03278); bR960 probe encodes amino acids 161-180 of the human PDGF b-receptor (nt 822 ± 1781); and bR33 probe encodes the C-terminal half of the receptor (nt 1675 ± 3804) including the transmembrane anchoring domain (TM), both tyrosine kinase domains (TK1 and TK2), the C-terminus, and 130 bp of 3'-UT. All constructs were con®rmed by DNA sequence analysis.
Northern blot analysis
Poly(A) + -enriched RNAs were isolated from cells by a direct capture method involving cell lysis in a buer containing proteinase K and SDS, followed by chromatography on oligo(dT)-cellulose (Schwab et al., 1983) . RNAs were denatured at 658C for 5 min, and then electrophoresed on a 1% agarose gel containing 2.2 M formaldehyde (16 MOPS buer). After a brief treatment of the gel in 50 mM NaOH (10 min) and neutralization in 0.5 M TrisHCl pH 7.5, the RNAs were blotted to 0.45 m Nytran membrane (Schleicher and Schuell, Keene, NH) by vacuum transfer in 106SSPE. Triplicate strips of each RNA were prepared in this manner and hybridized to the 32 P-labeled cDNA probes described above. Hybridization was at 438C in 50% formamide, 56SSPE, 100 mg/ml denatured salmon sperm DNA, 0.1% SDS, and 56 Denhardt's solution; blots were washed at high stringency (0.16 SSPE, 0.1% SDS, 568C). The hybridized blots were exposed to X-ray ®lms for 24 h.
Construction of the PDGF b-receptor cDNA library
Twice-selected poly(A) + RNA from the C10/MJ cell line was used to construct a cDNA library in lgt11 using oligo(dT) 12-18 as a primer and AMV reverse transcriptase at 428C. After brief treatment with mung bean nuclease and T4 DNA polymerase (250 mM dNTPs), double-stranded cDNAs were ®tted with EcoRI ± NotI linker adapters (Pharmacia), sized on Sepharose CL-4B, ligated into EcoRI-treated lgt11 arms (Promega Corp, Madison, WI), packaged with Gigapack Gold (Stratagene, San Diego, CA), and transformed into E. coli Y1090 r 7 m 7 (Promega); 675 000 recombinants resulted from 50 ng of linkered cDNA. This library was screened at 438C in 50% formamide using the C-terminal human PDGF b-receptor probe bR33; screening of 120 000 plaques resulted in four independent cDNA clones (bR01, bR02, bR08 and bR09) bearing cDNA inserts between 1.67 and 2.25 kb.
Genomic clones
Ampli®cation of genomic DNA was achieved after`hot start' (heating the template to 948C for 15 min, then cooling to 728C) followed by the immediate addition of the master mix for polymerase chain reaction (PCR) including (®nal concentrations) of: speci®c oligonucleotide primers (amplimers) at 0.3 mM, 50 mM KCl, 1.5 mM MgCl 2 , 10 mM Tris-HCl (pH 8.3 at 208C), 200 mM dNTPs, 0.001% gelatin, 0.1% Triton X-100 and 125-150 U/ml of Taq polymerase (Promega Corp., Madison, WI); the reactions were overlaid with a drop of mineral oil. Ampli®cation was carried out for 31 cycles of denaturation (45 s at 948C) annealing (25 s at 608C), and extension (1 min 15 s at 728C) followed by a single 10 min extension step at 728C in the Coy TempCycler II (Coy Corporation, Grass Lake, MI). Aliquots of the PCR reaction (1 ml) served as input to ligation reactions using the kanR/ampR plasmid pCRII provided in the TA Cloning System Kit (Invitrogen, Palo Alto, CA) according to manufacturer's directions. Portions of the ligation reaction were used to transform competent E. coli (strain XL-1 blue, Stratagene, San Diego, CA) and selected for kanamycin resistance on tetracycline-containing media. Cloned genomic DNAs were mapped by restriction enzyme digestion and DNA sequencing. The HTLV-Ispeci®c PCR primers included: ASG11: 5'-CTTCTA-GACGGCGGACGCAGTTC-3', an antisense primer in the R region of the LTR, and HTLK2: 5'-TTCAG-GAGGGGGCTCGCATCTCT-3', a sense primer in the U5 region of the LTR. PDGF b-receptor-speci®c PCR primers included the juxtamembrane exon antisense amplimer KDC2: 5'-CACCTTCCATCGGATCTCGTA AC-3', and the transmembrane exon-derived PCR sense amplimer K3: 5'-CATCTCCCTTATCATCCTCATCA-3'. DNA sequence analysis was done using non-radioactive methods, analysed on an Applied Biosystems DNA Sequencer Model 373 (Foster City, CA). Sequencing reactions included dye primers SP6 and T7 or dye terminators. For dye terminator reactions, internal primers used included IP1: 5'-TCTCATCCTAGCCATG-GAGCATGGGACC-3', IP4: 5'-ACACCTTAAGATGTC-AACATTCT-3', and IP7: 5'-GAGAAGCTAGAGAGGA-GGTTCTC-3', as shown in Figure 4 .
Plasmid expression constructs and soft agar assays
To test the transforming eciency of this putative of the 522 aa putative PDGF b-receptor-related protein, we prepared expression constructs derived from cDNAs cloned from the C10/MJ cells, driven by the Rous sarcoma virus (RSV) LTR. The ®rst construct, pRSV-bR08, encodes the 522 aa truncated PDGF b-receptor ORF, including the 109 bp HTLV-I leader sequence. For comparison, a second construct was created using a 1.43 kb cDNA derived from C10/MJ cells, featuring a 353 aa Tax ORF, also driven by the RSV-LTR (pRSV-Tax1). A third construct, pSM-1, harbors the full human PDGF-B/c-sis ORF (Clarke et al., 1984) , encoding the B chain of the PDGF ligand. Plasmid constructs were puri®ed by Qiagen chromatography (Qiagen, Chatsworth, CA) and introduced into subconuent NIH3T3 cells by calcium phosphate precipitation, and cells selected in DMEM medium containing 0.3% calf serum. Foci were cloned after 10 ± 14 days using cloning cylinders and grown in 0.3% calf serum. Anchorageindependent growth was measured after 7 days in soft agar (0.3% agarose, SeaPlaque); 6 cm diameter dishes were seeded with 3000 cells.
